Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

REMEDY ANTIFUNGAL 2% CREAM

Miconazole Nitrate
$0.0489per ML
OTC

Strength

2 g/100g

Manufacturer

Medline Industries, LP

NDC

53329016204

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

8/17/2016

Active Ingredients

MICONAZOLE NITRATE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M005

On Market Since

1/1/2007

Pharmacological Classes

Azole Antifungal
Azoles

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LOTRIMIN AF 2% POWDER
Brand
11523091901•Bayer HealthCare LLC
$0.0487
per GM
VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3451
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096301•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096307•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096305•Bayer HealthCare LLC
$0.5097
per GM
FUNGOID 2% TINCTURE
Brand
00884029301•Pedinol Pharmacal, Inc.
$0.5848
per ML
PYLERA 140-125-125 MG CAPSULE
Brand
61269038012•H2-Pharma LLC
$2.4283
per EA
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006675•Saptalis Pharmaceuticals LLC
$2.6042
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
81033006620•Kesin Pharma Corporation
$2.6093
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006620•Saptalis Pharmaceuticals LLC
$2.6175
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy